Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NPRO: Notification regarding TRS-agreement

In connection with expiry of the existing TRS, Carucel Invest AS, a company controlled by Carl Erik Krefting who is a board member of Norwegian Property ASA (NPRO), has on January 12, 2021 entered into a TRS agreement relating to 4 262 801 shares in NPRO. Pursuant to the TRS agreement the exercise price is NOK 13 per share and the termination date is January 14, 2022. Following the transaction Carucel Invest AS will have rights related to 4,262,801 shares through the TRS agreement and will continue to own 356,664 shares, in aggregate equal to 0.71% of the share capital of NPRO. In addition

Magnus Björnum new CFO at Inteno Group

Magnus Björnum has been appointed Chief Financial Officer at Inteno Group AB. Magnus comes from similar positions at companies such as Soft One, GM Financial and Jeeves. “Inteno Group is a company with big ambitions and great potential. The group combines product and software development within the broadband and IoT industry in an atmosphere, where solid business development meets startup”, says Magnus. “Genexis is well established within the European CPE market place with good track records within the growing Fiber to the Home and In-home WiFi segment. IOPSYS is different, a

New small antibodies show promising effects against COVID-19 infection

Researchers at Karolinska Institutet in Sweden have developed, in collaboration with researchers in Germany and the U.S., new small antibodies, also known as nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells. The research study, published in Science, shows that a combined nanobody had a particularly good effect – even if the virus mutated. According to the researchers, the nanobodies have the potential to be developed into a treatment for COVID-19.Specific proteins, spike proteins, on the surface of the SARS-CoV-2 coronavirus help the virus infect host cells.

Coor loses part of IFM contract with Equinor

Coor's agreement with Equinor in Norway consists of delivery of services to production sites, office sites and offshore. After performed tender process, Equinor has decided not to extend the office part of the contract when it expires in October 2021.The contract value for the office sites is approximately SEK 500 M annually. The production sites are not affected by this decision. The offshore part of the agreement was extended in March 2020. For more information, images etc. please visit www.coor.com or contact: Klas Elmberg, CFO and IR-director +46 10 559 65 80 klas.elmberg@

Neste and Avfuel create strategic partnership for sustainable aviation fuel

Neste Corporation, Press Release, 12 January 2021 at 4:10 p.m. (EET) Neste and Avfuel Corporation announce a strategic partnership to create an efficient, continuous supply of sustainable aviation fuel (SAF) in the United States. Neste will provide Avfuel with SAF in volumes able to meet the growing demands of Avfuel’s customers, including fixed base operators (FBOs), airports, flight departments, original equipment manufacturers (OEMs) and commercial operators. Avfuel will be a branded SAF distributor for Neste, and will sell it under the brand name Neste MY Sustainable

Invitation to Electrolux Q4 presentation

Electrolux results for the fourth quarter of 2020 will be published on February 2, 2021, at approximately 08.00 CET.A telephone conference will be held following the release of the results, starting at 09.00 CET. Jonas Samuelson, President and CEO and Therese Friberg, CFO will comment on the report. Slides used in the presentation will be available at Electrolux website, www.electroluxgroup.com/ir. The fourth quarter report will also be available at the same address. You can listen to the presentation here . The details for

WorkWave Wins Gold in 10th Annual Best in Biz Awards

WorkWave Payments recognized as Best New Product of the Year – SMB for its integrated payment processing solutionHolmdel, N.J., - January 12, 2021 - WorkWave , a leading provider of cloud-based software solutions that support every stage of a service business’s life cycle, today announces that its integrated payment processing solution, WorkWave® Payments , has been awarded Gold for Best New Product of the Year – SMB in Best in Biz Awards , the only independent business awards program judged

BNP PARIBAS HIRES SOFIA LÖNNQVIST FOR CAPITAL MARKETS NORDIC DIVISION

BNP Paribas continues to invest in the Nordic region with an appointment to further strengthening its leading position in Debt Capital Markets.Sofia Lönnqvist joins BNP Paribas Northern European Debt Capital Markets (DCM) Origination Team for Financial Institutions. She will be responsible for the Nordic region linking to our distribution and underwriting platform globally.   Sofia joins after 8 years at Barclays where she worked in DCM Nordics. She has experience in Rating Advisory and Investor relations at Barclays as well as working at UBS and Bank of America Merrill Lynch. Sofia will

Get your VPN questions answered

VPN A2Z (vpna2z.com) is a new service for everyone that needs internet access from a different geolocation than where they are."What is the purpose of using VPN?", "Which Browsers Have Built-In VPN?" or "Is it safe to do a bank transaction while connected to a VPN?". VPN A2Z  is the new place where they try to answer every question related to VPNs, as the questions above.  "It is our goal to make the absolute best resource online. Especially focussing on all the small and maybe a little weird questions, that people might have regarding VPNs" says Francky who is one of

Intervacc Announces Submission of Responses to EMA Day 120 Questions

Stockholm, January 12, 2021 - Intervacc AB (publ) announces that the responses to the Day 120 questions regarding the Company’s Marketing Authorization Application (MAA) for Strangvac has been submitted today to the European Medicines Agency (EMA). Intervacc is seeking approval for Strangvac as a vaccine against equine strangles, a highly contagious infectious disease that affects horses globally. After validating the submission and reviewing the responses, a second list of questions and outstanding issues is expected from the Committee for Medicinal Products for Veterinary Use (CVMP).

Aspire Global Expands Partnership with 888casino to Portugal

Aspire Global’s Pariplay has signed a partnership for games with 888 Holdings, covering Portugal. The partnership expands 888casino and Pariplay’s existing relationship, which has already seen 888 offer exciting titles by Pariplay for its UK, Romanian and Italian customers.On 26 November 2020, Aspire Global announced that Pariplay, a leading game studio and game aggregator, will be going live in the Spanish market with 888casino, a multi-award-winning online casino. Now players also in Portugal can enjoy Pariplay’s much loved titles including Wolf Riches, Mystic Manor, Rumble Rhino and

European Directories announces intra-group transaction of Herold by dogado

European Directories announces that its majority-owned subsidiary dogado GmbH will acquire the share capital of fully owned Austrian group company, Herold Business Data GmbH (“HEROLD”). The transaction results in the establishment of a leading provider offering the most comprehensive range of website and online marketing services for small and medium-sized businesses in Austria. Closing of the transaction is expected in February. The unification of HEROLD and dogado group creates a player with a unique strategic position in the digital market: both companies specialize in supporting

BioStock: Saniona's CEO on the plans for 2021

Saniona has an ambitious plan for 2021, including advancement of its primary drug candidate Tesomet, which targets the rare diseases hypothalamic obesity (HO) and Prader-Willi syndrome (PWS). Saniona’s US-based CEO Rami Levin talked to BioStock about the plans for the year, including the intention to start Phase IIb studies in both HO and PWS during the first half of the year.Read the full interview with Rami Levin at biostock.se: https://www.biostock.se/en/sanionas-ceo-on-the-plans-for-2021/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.

Bulletin from the Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ)

12 January 2021 – The Extraordinary General Meeting in InDex Pharmaceuticals Holding AB (publ) was held on 12 January 2021 at the offices of Setterwalls Advokatbyrå at Sturegatan 10, Stockholm. Attendance at the meeting was solely possible via postal voting. The following resolutions were passed at the general meeting.Resolution to amend the articles of associationThe general meeting resolved, in accordance with the board of director’s proposal, to amend the Company’s articles of association with respect to, inter alia, prerequisites for participation at general meetings, the limits for

Alma Media issues positive profit warning following better than anticipated profitability development in Q4

Alma Media Corporation                                         Inside information 12 January 2021 at 1.20 p.m.ALMA MEDIA ISSUES POSITIVE PROFIT WARNING FOLLOWING BETTER THAN ANTICIPATED PROFITABILITY DEVELOPMENT IN Q4 Alma Media raises its guidance for the 2020 adjusted operating profit for continuing operations. The adjusted operating profit for Q4 2020 falls short of the level of the comparison period, while fall in profitability is less than anticipated in 2020. The company expects that the adjusted operating profit for 2020 will decline less than 10 per cent of the comparison

BioStock: Ultimovacs announces collaboration with AstraZeneca

Ultimovacs announced this morning that it will be participating in a phase II study in collaboration with AstraZeneca, along with the Nordic Society of Gynaecological Oncology (NSGO) and the European Network of Gynaecological Oncological Trial Groups (ENGOT). The aim of the randomized clinical trial is to evaluate Ultimovacs' proprietary universal cancer vaccine, UV1, in combination with AstraZeneca's durvalumab and olaparib in patients with relapsed ovarian cancer.Read the full article at biostock.se: https://www.biostock.se/en/ultimovacs-announces-collaboration-with-astrazeneca/

Strong preclinical immunization data for the ABNCoV2 cVLP-based COVID-19 vaccine published in Nature Communications

Today, ExpreS2ion Biotech Holding AB and its affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") announces the publication of strong virus neutralization properties in animal proof-of-concept data for ABNCoV2, a unique capsid virus like particle (cVLP) based COVID-19 vaccine coated with ExpreS2-made SARS-CoV-2 antigens, in the esteemed scientific journal Nature Communications. The ABNCoV2 COVID-19 vaccine is the result of a strong collaboration effort by ExpreS2ion and its joint venture partner AdaptVac ApS (“AdaptVac”) together with the PREVENT-nCoV consortium, with an exclusive global

SimCorp A/S - Major shareholder announcement

With reference to Section 30 of Consolidated Act no. 377 of 2 April 2020 on capital markets, please be informed that SimCorp A/S January 12, 2021 was informed by The Capital Group Companies, Inc. that The Capital Group Companies, Inc. now owns 9.97% of the share capital and voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800). SimCorp A/S

Changes in Preem's Executive Management Team

Preem today announces changes in the Executive Management Team.The management team will, from 18 January, consist of: Magnus Heimburg, Chief Executive Officer (CEO) Lina Stolpe, Chief Financial Officer (CFO) Peter Abrahamsson, Executive vice president (EVP) Sustainable Development Magnus Holm, Executive vice president (EVP) Supply & Trading Christian Bjerdén, Executive vice president (EVP) Market and Sales Ylva Nyberg, Executive vice president (EVP) Communications & Human Resources Aad van Bedaf, Executive vice president (EVP) Refining

Assemblin El strengthens its position in the Uppsala region, Sweden, with the acquisition of J&C El

Assemblin El has acquired the well-positioned electrical engineering company J.Östling & C.Sparf El AB (J&C El), operating in Uppsala region. J&C El has annual sales of approximately SEK 45 million and 28 employees.Since its founding in 2011, J&C El has developed into a strong and professional electrical engineering company with a loyal customer base. The customer mix contains a variety of property companies, industries, construction companies, municipalities, and private individuals with a high level of service. – Uppsala, Sweden’s fourth largest city, is a strategic location for us,

SAS Traffic figures - December 2020

Increased passenger numbers compared to November driven by holiday travelAlmost 400,000 passengers flew with SAS during December, an increase of 18% compared to last month, but a decline by 80% year over year. At the same time SAS reduced its capacity by 6% compared to November, which corresponds to a reduction of 74% compared to last year. The load factor came in at 33%, an increase of some 8 percentage units (p.u.) compared to the previous month, but down 38 p.u. compared to last year. The increase in passengers and load factor compared to November is mainly driven by an increased demand

BioStock: Interview with CombiGene's new CMC expert

The Swedish Gene Therapy Company CombiGene aims to complete its preclinical program for the epilepsy project CG01 this year, in order to begin studies in humans in 2022. In this transitional phase, CombiGene has accelerated its recruitment process to occupy several key positions. BioStock has spoken with the newly recruited CMC expert Martin Linhult who, with his long experience of bringing pharmaceuticals to the market, will primarily focus on the manufacturing process of CG01.Read the full interview with Martin Linhult at biostock.se:  https://www.biostock.se/en/interview-with-

KHK Capital secures £25m funding facility to support growth

Property bridging and development lender, KHK Capital, has secured a £25 million funding line fromUK savings and lending specialist, Shawbrook Bank.The new financing line enables KHK Capital to meet rapidly growing demand from new and repeat customers for lending solutions on a diverse range of residential and commercial property.   "KHK Capital has been a 'family office' working mostly with private funds for a number of years," said Andy Kent, founding partner of KHK Capital. "We are very pleased to have secured this financing through Shawbrook Bank at a time when we are

There are no items matching the current filter
There are no more items matching the current filter
Back to top